D-1029-2020 Class III Terminated

Recalled by Strides Pharma Science Limited — Bangalore

FDA drug recall D-1029-2020 was initiated by Strides Pharma Science Limited on Feb 17, 2020 and is designated Class III. Reason for recall: Failed Tablet/Capsules Specifications: Oversized tablets were found in one lot of Potassium Chloride Tablets 750 mg. The recall status is terminated (terminated Feb 16, 2021). Affected quantity: 2576 bottles.

Recall details

Product Type
Drugs
Report Date
Mar 25, 2020
Initiation Date
Feb 17, 2020
Termination Date
Feb 16, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
2576 bottles

Product description

Potassium Chloride Extended-Release Tablets USP, 10mEq (750mg), 1000-count bottle, Rx only, Manufactured by: Strides Shasun Limited Bengaluru - 562106, India, Distributed by: Strides Pharma Inc., East Brunswick, NJ 08816, NDC 64380-861-08

Reason for recall

Failed Tablet/Capsules Specifications: Oversized tablets were found in one lot of Potassium Chloride Tablets 750 mg.

Distribution pattern

U.S.A. Nationwide

Code information

Lot #: 7238958A, 7238257A, Exp 7/31/2021; 7239404A, Exp 9/30/2021

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1029-2020
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1029-2020. Report a data issue: hello@regdatalab.com.